Rare diseases
Investigational molecules
Locations
Back to France659 clinical trials in Caen, France across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
FranceStudy on Clazakizumab for Heart Disease in Adults with End-Stage Kidney Disease on Dialysis
FranceA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
FranceAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
FranceA study of MK-1084 and pembrolizumab for patients with resected KRAS G12C-mutant non-small cell lung cancer
FrancePhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
FranceRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
FranceEfficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
FranceA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
FranceStudy of precemtabart tocentecan alone or in drug combination versus standard therapy in previously treated metastatic colorectal cancer patients
FranceCabozantinib Maintenance Therapy vs Best Supportive Care in Osteosarcoma Patients in Complete Remission or with Residual Disease after First‑Line Chemotherapy
FranceStudy of RMC-6291 with ivonescimab drug combination in patients with advanced RAS‑mutated solid tumors
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple cancer types including head and neck squamous cell carcinoma, endometrial cancer, and multiple myeloma. Studies evaluate novel therapeutic combinations and treatment strategies.
Trials investigate targeted therapies and immunotherapy approaches for improved patient outcomes.
Studies examining prevention and treatment of respiratory infections, with focus on respiratory syncytial virus (RSV) in vulnerable populations. Investigation of novel antibiotics for prosthetic joint infections.
Research aims to develop effective preventive strategies and therapeutic interventions.
Research exploring treatments for heart failure prevention and management of cardiovascular conditions. Studies evaluate antiplatelet therapy strategies in elderly patients following interventional procedures.
Focus on improving cardiovascular outcomes through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
